Search Results 51-60 of 16321 for Alirocumab

  1. Olaparib, Cediranib Maleate, and Standard Chemotherapy in Treating Patients With Small Cell Lung Cancer - Mayo Clinic

    Drugs used in chemotherapy, such as carboplatin, cisplatin, and etoposide, work in different ways to stop the growth of tumor cells, either by killing the cells ...

  2. Biological Therapy For Cancer Clinical Trials - Mayo Clinic Research

    This study will test a study drug called cemiplimab to see if it can help treat early-stage cutaneous squamous cell carcinoma (CSCC), a type of skin cancer.

  3. Olaparib in Treating Patients With Metastatic Biliary Tract Cancer With Aberrant DNA Repair Gene Mutations - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. Clinical trials - Oncology (Medical)

    The purpose of this study is to compare the effects (good and bad) on patients with prostate cancer by comparing the standard dose of radiation therapy (44 ...

  5. Breast Clinic - Clinical trials

    This research is being done to evaluate the safety and tolerability of the new drug, axatilimab, in combination with olaparib (a standard of care treatment) ...

  6. Clinical trials - Oncology (Medical)

    The purpose of this study is to evaluate invasive disease-free survival (iDFS) of multi-epitope HER2 vaccine vs. placebo in combination with ado-trastuzumab ...

  7. Abacavir, lamivudine, and zidovudine (oral route) - Side effects & dosage - Mayo Clinic

    Abacavir, lamivudine, and zidovudine combination is used alone or together with other medicines to treat human immunodeficiency virus (HIV) infection. HIV is ...

  8. Brolucizumab-dbll (intraocular route) - Side effects & uses - Mayo Clinic

    Brolucizumab-dbll injection is used to treat neovascular (wet) age-related macular degeneration (AMD). AMD is a disorder of the retina in the eye that causes ...

  9. Targeted Drug Therapy Clinical Trials - Mayo Clinic Research

    Among persons with Immunoglobulin G subclass 4 Related Disease (IgG4)-related disease who have persistent or recurrent disease despite standard therapies, does ...

  10. Elranatamab-bcmm (subcutaneous route) - Side effects & uses - Mayo Clinic

    Elranatamab-bcmm injection is used to treat relapsed (cancer that has come back) or refractory (cancer that did not respond to treatment) multiple myeloma in ...